cerca CERCA
Domenica 07 Marzo 2021
Aggiornato: 16:04
Temi caldi

CHIMICA E FARMACEUTICA

icometrix expands icobrain portfolio with ischemic stroke solution

LEUVEN, Belgium and BOSTON, Feb. 23, 2021 /PRNewswire/ -- icometrix, world leader in imaging AI solutions for people with neurological conditions, announced the addition of icobrain cva, a stroke solution, to the icobrain portfolio. The announcement follows the FDA-clearance and CE-marking of its image processing software for the analysis and communication of the tissue perfusion state on computer tomography (CT) perfusion scans in patients with ischemic stroke. icobrain cva provides physicians w...

Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A

LACHEN, Switzerland, Feb. 22, 2021 /PRNewswire/ -- Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. "Simoctocog Alfa (Nuwiq®) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study" https://www.thieme-connect.com/products/ejournals/abstra...

Willow Biosciences Announces Exercise of Over-Allotment Option and Completion of Previously Announced Bought Deal Offering

VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/ -- Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of 17,424,800 common shares (the "Common Shares") of the Company at a price of $1.65 per Common Share, which includes 2,272,800 Common Shares issued pursuant to the exercise in full of the over-allotment option, for aggregate gross proceeds of approximately $28.75 m...

Gerresheimer presents strong fourth quarter

DÜSSELDORF, Germany, Feb. 18, 2021 /PRNewswire/ -- Gerresheimer AG posted strong growth in the fourth quarter of 2020 and landed inside the target range despite the negative impact of the COVID-19 pandemic. "Business in the fourth quarter was very strong. It was the best quarter in the Company's history. Despite the negative impact of the coronavirus pandemic, especially in our cosmetics business, we reached our goals for 2020. The successful acceleration of growth in large parts of our core busi...

Noma Medical Crisis: le leggende del calcio africano lanciano un appello per le donazioni per salvare i "bambini senza volto"

PARIGI, 16 febbraio 2021 /PRNewswire/ -- Sebbene ogni anno colpisca più di 140.000 bambini, il noma rimane una malattia pressochè sconosciuta per il grande pubblico. Derivata dal greco "nomein", che significa "divorare", la malattia distrugge il viso, causando la morte del bambino nel 90% dei casi. Per combattere questo flagello, nel 2019, l'ex calciatore Roger Milla ha fondato l'associazione Noma Fund. Insieme a ex giocatori internazionali come Joseph-Antoine Bell, François Omam-Biyik, Patrick M...

Medicom Healthcare Ltd announces the signing of an Asset Purchase Agreement of BIMATOPROST 0.3 mg/mL, 3ml

LONDON, Feb. 10, 2021 /PRNewswire/ -- Medicom Healthcare Limited (Medicom) and Famar Health Care Services Madrid (Famar) are pleased to announce the signing of an Asset Purchase Agreement (APA) for the acquisition by Medicom of the pharmaceutical dossier of BIMATOPROST 0.3 mg/mL, 3ml, preservative free eye drop solution, developed by Famar R&D. Under this agreement, Medicom has acquired the ownership of the product dossier which is already registered in the UK and 5 EU countries with plans to com...

Wondfo - Neutralizing antibody testing, antigen testing and PCR key in battle against COVID-19 in 2021

GUANGZHOU, China, Feb. 1, 2021 /PRNewswire/ -- Wondfo is ramping up neutralizing antibody, antigen and PCR tests to address the evolving demands for COVID-19 testing globally. As countries draw up plans to deal with the new wave of infections amidst the pandemic while vaccination programmes are rolled out, Wondfo remains resolute and agile to provide healthcare authorities with the specific tests they need to apply appropriate testing strategies that can help bring the pandemic under control.

2021 Japan Prize Laureates Announced

TOKYO, Jan. 29, 2021 /PRNewswire/ -- The winners of the 2021 Japan Prize were announced on January 29 by the Japan Prize Foundation and its president, Hiroshi Komiyama. The newest laureates are Australian researcher Prof. Martin Andrew Green, honored for his work in the field of "Resources, Energy, the Environment, and Social Infrastructure," and U.S. researchers Prof. Bert Vogelstein and Dr. Robert A. Weinberg, joint winners for their work in the field of "Medical Science and Medicinal Science."...

ora in
Prima pagina
Tag più usati
in questa pagina

attività process materials

biomass energy facility plant

chimica_e_farmacia salute_e_benessere salute_e_benessere salute_e_benessere chimica_e_farmacia economia_e_finanza economia_e_finanza economia_e_finanza

chimica_e_farmacia meccanica altro economia_e_finanza

first generation pharmaceutical company will

holding company that

importante fornitore

newly founded investment

presentazione di aerovac

articoli
in Evidenza